5.06
-0.46(-8.33%)
Currency In USD
| Previous Close | 5.52 |
| Open | 4.89 |
| Day High | 5.49 |
| Day Low | 4.8 |
| 52-Week High | 10.45 |
| 52-Week Low | 1.61 |
| Volume | 576,733 |
| Average Volume | 2.24M |
| Market Cap | 8.56M |
| PE | 0.8 |
| EPS | 6.32 |
| Moving Average 50 Days | 2.39 |
| Moving Average 200 Days | 3.3 |
| Change | -0.46 |
If you invested $1000 in Qualigen Therapeutics, Inc. (QLGN) 10 years ago, it would be worth $0.02 as of September 29, 2025 at a share price of $5.06. Whereas If you bought $1000 worth of Qualigen Therapeutics, Inc. (QLGN) shares 5 years ago, it would be worth $2.07 as of September 29, 2025 at a share price of $5.06.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Faraday Future Announces Strategic $41 Million Investment in Qualigen Therapeutics, Inc. (NASDAQ: QLGN) f for Crypto Business Through PIPE Transaction
GlobeNewswire Inc.
Sep 19, 2025 10:01 PM GMT
LOS ANGELES and CARLSBAD, Sept. 19, 2025 (GLOBE NEWSWIRE) -- Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, and Qualig
Qualigen Therapeutics Provides Update on Nasdaq Communications and Continued Listing Status
GlobeNewswire Inc.
Jul 28, 2025 9:20 PM GMT
CARLSBAD, Calif., July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) received two different communications from the staff of the Nasdaq Listing Qualifications office of the Nasdaq Stock Market, LLC. The Com
Qualigen Therapeutics Announces $4.5 Million Private Placement of Series A-3 Convertible Preferred Stock
GlobeNewswire Inc.
Jul 28, 2025 4:41 PM GMT
Carlsbad, CA, July 28, 2025 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ:QLGN) ("Qualigen" or the "Company"), a life sciences company focused on developing platform treatments for adult and pediatric cancers with the potential for orphan